Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,164 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07876648Recruiting
New PET scan for endometriosis
This trial tests whether a special PET scan can help doctors see endometriosis tissue during a routine laparoscopy. The scan may light up active disease and help guide treatment decisions.
LeuvenAges 18–64 - NCT07296744Recruiting
Study of a heart pump for high-risk angioplasty
This trial tests a new device called the Supira system to support the heart during a high-risk procedure to open blocked arteries. It is for people who are stable enough to wait for the procedure (not in emergency or shock).
Loma Linda, CaliforniaAges 18–90 - NCT07238556Recruiting
Digital exercise program for cardiovascular risk
This study tests a new digital tool that helps clinicians prescribe personalized exercise plans to patients with cardiovascular risk factors like high blood pressure, diabetes, or obesity. Participation involves using the tool and following an exercise plan for a few months to see if it improves health.
Farmington, ConnecticutAges 18–64 - NCT07095634Recruiting
Heart risk study for Crohn's and colitis patients
This study looks at heart health in people with Crohn's disease or ulcerative colitis. It aims to understand the risk of heart problems over 2 years.
San Donato Milanese, MilanAges 16 years+ - NCT06879041RecruitingPhase 1
Study of a radioactive drug for advanced prostate cancer
This study tests a new radioactive drug, [225Ac]-AZD2284, for men with prostate cancer that has spread and no longer responds to hormone therapy. The drug is designed to target cancer cells and deliver radiation directly to them, potentially slowing the cancer's growth.
Palo Alto, CaliforniaAges 18 years+ - NCT06782373RecruitingPhase 2
Pacritinib for VEXAS syndrome
This trial tests whether the drug pacritinib can safely reduce inflammation and improve symptoms in people with VEXAS syndrome, a rare genetic condition that causes inflammation in various parts of the body. It may be a new treatment option for those who still have inflammation despite taking steroids.
Scottsdale, ArizonaAges 18 years+ - NCT07877090Recruiting
Brain activity during anesthesia in people with obesity
This study looks at how anesthesia affects brain waves in people with obesity compared to people with normal weight. It may help doctors understand if anesthesia needs to be adjusted for people with obesity.
Düzce, DüzceAges 18 years+ - NCT07085442Recruiting
Audit of targeted lymph node biopsy for early breast cancer
This study looks at how well a special type of lymph node biopsy works for people with early breast cancer that has spread to a small number of lymph nodes. It aims to see if this approach is effective and safe, which may help guide future treatment decisions.
BurnleyAges 18 years+ - NCT06466382Recruiting
Personalized cancer therapy for advanced ovarian cancer
This trial tests whether a treatment plan tailored to your specific tumor and health can work better for advanced ovarian, peritoneal, or fallopian tube cancer. It aims to find the best therapy for each patient to improve outcomes.
Baden, Canton of AargauAges 18 years+ - NCT07626216Recruiting
Brain stimulation for muscle spasms
This study tests whether a non-invasive brain stimulation treatment called repetitive transcranial magnetic stimulation (rTMS) can help reduce abnormal muscle spasms in people with dystonia. It uses MRI to see how the brain changes with the treatment.
Manhasset, New YorkAges 18–80 - NCT07877948Recruiting
Combination therapy for diabetic nerve pain and foot ulcers
This study tests whether a treatment called Bionerv E+ helps with nerve pain and healing of foot ulcers in people with type 2 diabetes, compared with a standard vitamin B complex. If you have diabetes-related nerve damage and a foot ulcer that is not too severe, this study might help you understand if this new option works.
Cheras, Kuala LumpurAges 18 years+ - NCT07585578Recruiting
Understanding long-term effects after critical illness
This study looks at how chronic critical illness affects patients' thinking, physical abilities, and emotional well-being after leaving the intensive care unit. It may help improve care and support for people who are still dependent on hospital care.
Huaibei, AnhuiAges 18 years+ - NCT07219771RecruitingPhase 3
Knee injection for osteoarthritis pain
This study tests a single injection of PTP-001 (MOTYS™) into the knee to see if it reduces osteoarthritis pain. It is for people whose knee pain is their main pain problem and who haven't found relief from standard pain medicines.
Birmingham, AlabamaAges 40–80 - NCT07877350Recruiting
Breathing effort and breathlessness in ICU patients on a ventilator
This study looks at how the effort patients make to breathe relates to feelings of breathlessness while they are on a breathing machine in the intensive care unit. It may help doctors better manage breathing support to reduce discomfort.
HeraklionAges 18 years+ - NCT07878754RecruitingPhase 1
Remote monitoring for depression treatment
This study tests whether remote monitoring through a smartphone, computer, or tablet can help people with depression who are starting a new antidepressant. It aims to see if this approach improves care and outcomes.
BronAges 18 years+ - NCT07877376Recruiting
How thinking problems affect pain in breast cancer survivors
This study looks at whether mild memory or thinking issues after breast cancer treatment are linked to ongoing pain. If you join, you will help doctors understand this connection, which may lead to better pain care.
Boulogne-Billancourt, IDEAges 35–65 - NCT07878884Recruiting
Light therapy with lung rehab for severe COPD
This trial tests whether adding light therapy to a standard exercise program helps people with severe COPD breathe better and do more in their daily lives. It might be especially helpful if you have advanced COPD and can still walk.
Porto Alegre, Rio Grande do SulAges 18–90 - NCT07159620RecruitingPhase 2
Combination treatment for a rare type of T-cell leukemia
This trial tests a combination of drugs for people newly diagnosed with a rare and aggressive type of T-cell acute lymphoblastic leukemia (ETP-ALL). The goal is to see if this combination can help put the leukemia into remission.
Suzhou, JiangsuAges 14–75 - NCT07569263RecruitingPhase 1
CAR T cell therapy for brain metastases
This trial tests a new kind of cell therapy that uses your own immune cells (modified to attack cancer) to treat brain metastases. It may help people whose cancer has spread to the brain and hasn't responded to other treatments.
Gainesville, FloridaAges 18–80 - NCT06028022RecruitingPhase 2
Reishi mushroom for fatigue and joint/muscle pain in breast cancer
This trial tests whether a reishi mushroom extract can help reduce fatigue and joint or muscle pain in people with breast cancer who are taking aromatase inhibitors. If you have these symptoms, you may be able to join.
Albert Lea, MinnesotaAges 18 years+ - NCT07237308RecruitingPhase 4
Two blood thinners compared for stroke with atrial fibrillation
This study tests whether a common blood thinner (apixaban) alone is as safe and effective as combining it with another drug (clopidogrel) to prevent future strokes in people who have both atrial fibrillation and narrowing in the arteries leading to the brain. It aims to find the best way to reduce stroke risk while minimizing bleeding.
SeoulAges 19 years+ - NCT07714018Recruiting
Comparing two weight loss programs for kidney cancer patients
This study tests two different weight loss programs to see which one helps prevent kidney cancer from growing in people with small kidney masses who are under active surveillance. It may help by improving overall health and potentially slowing cancer progression.
Buffalo, New YorkAges 18 years+ - NCT07463807RecruitingPhase 1/Phase 2
Comparing two drug combinations for multiple myeloma that returned quickly
This study tests a new combination of two drugs, teclistamab and pomalidomide, against the usual treatment of three drugs for multiple myeloma that has come back shortly after a standard treatment. The goal is to see if the new combination works better or is safer.
Duarte, CaliforniaAges 18 years+ - NCT07226726RecruitingPhase 1
Stem cell exosome treatment for congenital myasthenic syndrome
This trial tests a treatment made from stem cell exosomes (tiny particles that may help repair cells) for people with congenital myasthenic syndrome, a muscle-weakening condition. It aims to see if this treatment is safe and could improve symptoms.
Naples, FloridaAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,164 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.